跳到主要內容區塊
:::

內分泌新陳代謝科

Print
    朱志勳 CHU Chih-Hsun
    朱志勳 CHU Chih-Hsun
    看診科別
    現職
    • 新陳代謝科主任
    主治專長
    • 新陳代謝及內分泌疾病
    • 甲狀腺門診
    學歷
    • 國立中山大學生物科學研究所碩士
    • 中國醫藥學院醫學系26屆醫學士
    經歷
    • 高雄榮民總醫院內科部新陳代謝科主治醫師
    • 高雄榮民總醫院內科部新陳代謝科總住院醫師
    • 高雄榮民總醫院內科部住院醫師
    • 龍泉榮民醫院住院醫師
    代表著作
    • 計畫:
    • 1.2019-2021: SGLT2 inhibitor on AMPK, MAP4K4 and sarcopenia in elderly T2DM
    • 2.2020-2021: Efficacy and Safety of a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin
    • 3.2021-2023: Investigation of the risk factors associated with diabetic peripheral neuropathy in type 2 diabetes
    • 4.2023-Present: Prospective Comparison of Connected Solution (Health2Sync) and Usual Care in Adult Participants with Type 2 Diabetes Mellitus Using Basal Insulin in Taiwan
    • 著作:
    • 1.Chia-Fen Wang, Chih-Hsun Chu. Suprasellar Astrocytoma in a Patient with Type 2 Diabetes Mellitus Presenting with Concurrent Central Diabetes Insipidus. Formos J Endocrinol Metab 13: 96-101, 2022
    • https://doi.org/10.6856/FJEM.202212_13(2).0013
    • 2.Chuang WC, Chu CH, Hsu YH, Yao CS. Effect of socioeconomic status on survival in patients on the Diabetes Shared Care Program: Finding from a Taiwan nationwide cohort. J Chin Med Assoc. 2022 Mar 1
    • 85(3):311-316.
    • 3.Wang CY, Huang KC, Lu CW, Chu CH, Huang CN, Chen HS, Lee IT, Chen JF, Chen CC, Chen CS, Hsieh CH, Tien KJ, Chien HY, Huang YY, Hsu JP, Shane GT, Chang AC, Wu YC, Sheu WH. A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes. J Clin Endocrinol Metab. 2022 Sep 28
    • 107(10):e4063-e4071.
    :::